Ken Griffin Citius Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 24,700 shares of CTXR stock, worth $12,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,700

Holding current value

$12,844

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.03 $107,656 - $191,182	185,614 New	185,614 $107,000
Q3 2023 Nov 14, 2023	BUY	$0.65 - $1.25 $2,641 - $5,080	4,064 Added 516.39%	4,851 $3,000
Q2 2023 Aug 14, 2023	SELL	$1.08 - $1.65 $93,445 - $142,764	-86,524 Reduced 99.1%	787 $0
Q1 2023 May 15, 2023	SELL	$0.78 - $1.42 $237,792 - $432,904	-304,862 Reduced 77.74%	87,311 $102,000
Q4 2022 Feb 14, 2023	BUY	$0.79 - $1.28 $225,778 - $365,817	285,795 Added 268.66%	392,173 $309,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.33 $18,128 - $172,224	-129,492 Reduced 54.9%	106,378 $129,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.87 $108,987 - $231,597	123,849 Added 110.56%	235,870 $217,000
Q1 2022 May 16, 2022	SELL	$1.38 - $1.89 $36,008 - $49,315	-26,093 Reduced 18.89%	112,021 $200,000
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.2 $34,338 - $50,030	22,741 Added 19.71%	138,114 $212,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.6 $163,272 - $243,971	-93,835 Reduced 44.85%	115,373 $234,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $273,610 - $766,471	181,199 Added 646.93%	209,208 $728,000
Q1 2021 May 17, 2021	BUY	$1.04 - $2.34 $9,482 - $21,336	9,118 Added 48.27%	28,009 $50,000
Q4 2020 Feb 16, 2021	BUY	$0.9 - $1.2 $17,001 - $22,669	18,891 New	18,891 $19,000
Q3 2020 Nov 16, 2020	SELL	$0.83 - $1.51 $14,472 - $26,329	-17,437 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.65 - $1.45 $4,410 - $9,838	6,785 Added 63.7%	17,437 $20,000
Q1 2020 May 15, 2020	BUY	$0.46 - $1.3 $4,899 - $13,847	10,652 New	10,652 $6,000
Q2 2019 Aug 14, 2019	SELL	$0.93 - $1.38 $24,708 - $36,663	-26,568 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.86 - $1.53 $22,848 - $40,649	26,568 New	26,568 $0

Others Institutions Holding CTXR

# of Institutions

Shares Held

30.6M

Call Options Held

24.7K

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $76M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account